Venatorx Pharmaceuticals is a private pharmaceutical company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections.
View Top Employees from Venatorx Pharmaceuticals, Inc.| Website | https://www.venatorx.com/ |
| Revenue | $10 million |
| Funding | $54.9 million |
| Employees | 78 (78 on RocketReach) |
| Founded | 2010 |
| Address | 74 E Swedesford Road Suite 100, Malvern, Pennsylvania 19355, US |
| Phone | (610) 644-8935 |
| Technologies |
JavaScript,
HTML,
PHP
+25 more
(view full list)
|
| Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Biotechnology, Drug Discovery, Healthcare, Science and Engineering, Health Care, Medical, Pharmaceutical |
| Web Rank | 11 Million |
| Keywords | Venatorx, Vnrx-5133, Venato Rx |
| Competitors | Cempra Pharmaceuticals, Microcide, Nabriva Therapeutics plc, Sequella, Inc., Tetraphase Pharmaceuticals |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Venatorx Pharmaceuticals, Inc. employee's phone or email?
Venatorx Pharmaceuticals, Inc. Questions
The Venatorx Pharmaceuticals, Inc. annual revenue was $10 million in 2024.
William Sargent is the Senior Vice President, Commercial Strategy of Venatorx Pharmaceuticals, Inc..
78 people are employed at Venatorx Pharmaceuticals, Inc..
Venatorx Pharmaceuticals, Inc. is based in Malvern, Pennsylvania.
The NAICS codes for Venatorx Pharmaceuticals, Inc. are [3254, 32541, 325, 32].
The SIC codes for Venatorx Pharmaceuticals, Inc. are [28, 283].
Top Venatorx Pharmaceuticals, Inc. Employees
-
ViewWilliam Sargent
Senior Vice President, Commercial Strategy at Venatorx Pharmaceuticals, Inc.
Malvern, Pennsylvania, United States33 -
35+
-
View
Paul McGovern
Senior Vice President Medical Sciences at Venatorx Pharmaceuticals, Inc.
Philadelphia, PA, US21 -
42
-
42
-
13
Related Companies
